SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-014307
Filing Date
2019-04-30
Accepted
2019-04-30 16:22:51
Documents
5
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A scph-defa14a_20190430.htm DEFA14A 47495
2 GRAPHIC g1jojae1tg2b000004.jpg GRAPHIC 10827
3 GRAPHIC g1jojae1tg2b000003.jpg GRAPHIC 18573
4 GRAPHIC g1jojae1tg2b000001.jpg GRAPHIC 39394
5 GRAPHIC g1jojae1tg2b000002.jpg GRAPHIC 61002
  Complete submission text file 0001564590-19-014307.txt   227779
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38293 | Film No.: 19782094
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1